Links (for anyone who wants to go deeper): Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation https://bio.news/latest-news/breaking-barriers-to-a-cure-patient-perspectives-matter-in-type-1-diabetes-innovation/Medicenna – Updates MDNA11 Clinical Trial Results at ESMO-IO Congress 2025 https://www.biotech.ca/news/medicenna-therapeutics-corp-updates-mdna11-clinical-trial-results-at-the-esmo-io-congress-2025-further-bolstering-its-anti-tumor-activity-in-advanced...
All content for BioTech Weekly is the property of Ernst Oberortner and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Links (for anyone who wants to go deeper): Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation https://bio.news/latest-news/breaking-barriers-to-a-cure-patient-perspectives-matter-in-type-1-diabetes-innovation/Medicenna – Updates MDNA11 Clinical Trial Results at ESMO-IO Congress 2025 https://www.biotech.ca/news/medicenna-therapeutics-corp-updates-mdna11-clinical-trial-results-at-the-esmo-io-congress-2025-further-bolstering-its-anti-tumor-activity-in-advanced...
Sources: AMR Drugs and Diagnostics Must Evolve in TandemMEDICURE – ANNOUNCES UPDATE ON ENROLLMENT IN ITS MEND-PNPO PHASE 3 CLINICAL TRIAL AND PRESENTATION OF THE TRIAL DESIGN AND BASELINE DATA AT THE 2025 CHILD NEUROLOGY SOCIETY CONFERENCEUnlocking the Potential of Transcription FactorsKapoose Creek Bio – Partners with Terrain Life Science to Advance Study of Lead Compound KCB-100What Comes Next? Industry Takeaways from FDA’s Cell and Gene Therapy Listening SessionVariational AI – Enters Coll...
BioTech Weekly
Links (for anyone who wants to go deeper): Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation https://bio.news/latest-news/breaking-barriers-to-a-cure-patient-perspectives-matter-in-type-1-diabetes-innovation/Medicenna – Updates MDNA11 Clinical Trial Results at ESMO-IO Congress 2025 https://www.biotech.ca/news/medicenna-therapeutics-corp-updates-mdna11-clinical-trial-results-at-the-esmo-io-congress-2025-further-bolstering-its-anti-tumor-activity-in-advanced...
